Symbols

CDMO(Delisted)

Avid Bioservices·NASDAQ

--(--)

Signals Analysis

Bullish signal 0

Bearish signal 1

Low Cash Short-term Debt Ratio

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CDMO

Avid Bioservices, Inc.

An American contract manufacturer

Industry

Established Date

Listing Date

04/01/1996

Exchange

NASDAQ Stock Exchange

Full-time Employees

371

Fiscal Year Ends

04-30

Website

www.avidbio.com

Security Type

Common stock

Office address

14191 Myford Road, Tustin, California 92780

Business

Introduction

Avid Bioservices, Inc., was originally incorporated in California in June 1981 and re-incorporated in Delaware on September 25, 1996. The Company is a specialized contract development and manufacturing organization (" CDMO ") that provides full-service (" CGMP ") clinical and commercial manufacturing from process development to current good manufacturing practices, focusing on the extraction of biopharmaceuticals from mammalian cell culture.

Company Financials

EPS

CDMO has released its 2025 Q2 earnings. EPS was reported at -0.27, versus the expected -0.1, missing expectations. The chart below visualizes how CDMO has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CDMO has released its 2025 Q2 earnings report, with revenue of 33.48M, reflecting a YoY change of 31.84%, and net profit of -17.41M, showing a YoY change of -82.82%. The Sankey diagram below clearly presents CDMO's revenue sources and cost distribution.